The saga of our early experiences with drug metabolism studies in the Parke-Davis Research Laboratories continues with a brief resume of the behavior of chloramphenicol under unusual clinical conditions and a consideration of the toxic effects of this drug and its metabolites in laboratory animals and in humans. The dose-related reversible effects of chloramphenicol upon the ferrokinetic pattern and cellular respiration are clearly separated from its nonreversible effects on the bone marrow cells of susceptible individuals. A number of possible research approaches are suggested for the exploration of these problems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00007691-198709000-00012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!